Use of biologics to treat relapsing and/or refractory eosinophilic granulomatosis with polyangiitis: data from a European collaborative study

A Canzian, N Venhoff, ML Urban… - Arthritis & …, 2021 - Wiley Online Library
Objective To describe the efficacy and safety of biologics for the treatment of eosinophilic
granulomatosis with polyangiitis (EGPA). Methods A retrospective European collaborative …
被引用次数：73 相关文章

Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.

A Canzian, N Venhoff, ML Urban… - Arthritis & …, 2021 - europepmc.org
Objective To describe the efficacy and safety of biologics for the treatment of eosinophilic
granulomatosis with polyangiitis (EGPA). Methods A retrospective European collaborative …

Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis: data from a European Collaborative Study

A Canzian, N Venhoff, ML Urban, S Sartorelli… - ARTHRITIS & …, 2020 - flore.unifi.it
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis with
Polyangiitis: data from a European Collaborative Study IRIS IRIS Home Sfoglia …

[引用][C] Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis: data from a European Collaborative Study.

A Canzian, N Venhoff, M Urban, S Sartorelli… - ARTHRITIS & …, 2020 - iris.unisr.it

Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.

A Canzian, N Venhoff, ML Urban… - Arthritis & …, 2021 - search.ebscohost.com
Objective: To describe the efficacy and safety of biologics for the treatment of eosinophilic
granulomatosis with polyangiitis (EGPA). Methods: A retrospective European collaborative …

Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study

A Canzian, N Venhoff, ML Urban… - Arthritis & …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To describe the efficacy and safety of biologics for the treatment of eosinophilic
granulomatosis with polyangiitis (EGPA). Methods A retrospective European collaborative …